Company Filing History:
3 out of 499 
2 out of 2,352 Years Active: 1996-2006
Title: Daiji Naka: Innovator in Antibody Research
Introduction
Daiji Naka is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to his name, Naka's work has advanced the understanding and application of hepatocyte growth factor activator inhibitors.
Latest Patents
Naka's latest patents include groundbreaking innovations in antibody technology. One of his notable patents is for an antibody to hepatocyte growth factor activator inhibitor-1 and its use. This patent describes a hybridoma that produces a monoclonal antibody with high reactivity to soluble hepatocyte growth factor activator inhibitor-1 (soluble HAI-1). The target monoclonal antibody is prepared from the culture supernatant of the obtained hybridoma, allowing for the measurement of soluble HAI-1 using this antibody. Another significant patent focuses on a specific antibody directed to active hepatocyte growth factor activator (HGFA). This antibody recognizes active HGFA while not substantially recognizing its inactive form. The patent also discloses a monoclonal antibody and a hybridoma cell line for producing it, along with methods for measuring active HGFA and detecting diseases through this measurement.
Career Highlights
Throughout his career, Daiji Naka has worked with leading companies in the chemical and biotechnology sectors. He has been associated with Mitsubishi Kasei Corporation and Mitsubishi Chemical Corporation, where he has contributed to various research and development projects. His expertise in antibody research has positioned him as a key figure in the field.
Collaborations
Naka has collaborated with notable colleagues, including Naomi Kitamura and Keiji Miyazawa. These collaborations have further enriched his research and have led to advancements in the development of innovative antibody technologies.
Conclusion
Daiji Naka's contributions to antibody research have had a significant impact on biotechnology. His innovative patents and collaborations highlight his role as a leading inventor in this field. His work continues to influence the development of new diagnostic and therapeutic methods.